Zurich Cantonal Bank’s Celyad Oncology SA American Depositary Shares CYAD Stock Holding History

Zurich Cantonal Bank’s Portfolio CYAD Stock Details CYAD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-100	Closed	-$1K	–	2640
2019 Q3	$1K	Hold	100	–	–	﹤0.01%	2615
2019 Q2	$1K	Hold	100	–	–	﹤0.01%	2612
2019 Q1	$2K	Hold	100	–	–	﹤0.01%	2567
2018 Q4	$2K	Hold	100	–	–	﹤0.01%	2590
2018 Q3	$3K	Hold	100	–	–	﹤0.01%	2580
2018 Q2	$3K	Hold	100	–	–	﹤0.01%	2524
2018 Q1	$3K	Hold	100	–	–	﹤0.01%	2534
2017 Q4	$4K	Hold	100	–	–	﹤0.01%	2539
2017 Q3	$6K	Buy	+100	New	+$4.49K	﹤0.01%	2488
2017 Q2	–	Sell	-1,560	Closed	-$42K	–	2581
2017 Q1	$42K	Sell	1,560 -8,833	-85%	-$192K	﹤0.01%	1872
2016 Q4	$187K	Sell	10,393 -7,368	-41%	-$140K	﹤0.01%	993
2016 Q3	$419K	Buy	17,761 +600	+3%	+$14.5K	﹤0.01%	865
2016 Q2	$429K	Buy	17,161 +3,426	+25%	+$163K	0.01%	845
2016 Q1	$601K	Buy	13,735 +3,061	+29%	+$125K	0.01%	806
2015 Q4	$581K	Buy	10,674 +422	+4%	+$18.6K	0.01%	812
2015 Q3	$429K	Buy	+10,252	New	+$528K	0.01%	854

Other funds holding CYAD

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

PSI Advisors Tampa, Florida $430M AUM 23.45% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

Zurich Cantonal Bank's CYAD Position: Q4 2019 in Review

Zurich Cantonal Bank sold out of Celyad Oncology SA American Depositary Shares (CYAD) in Q4 2019, closing a stake of 100 shares — an estimated $1K sold.

Zurich Cantonal Bank first reported a position in CYAD in Q3 2015 and held it in 16 quarters. The position peaked at $601K in Q1 2016. 9 funds tracked by Wall St. Rank hold CYAD as of Q4 2019.

Zurich Cantonal Bank reported no remaining Celyad Oncology SA American Depositary Shares position as of Q4 2019 after selling out during the quarter.
Zurich Cantonal Bank sold 100 Celyad Oncology SA American Depositary Shares shares in Q4 2019, an estimated $1K.
Zurich Cantonal Bank first reported a position in Celyad Oncology SA American Depositary Shares in Q3 2015 and held it in 16 quarters.
Zurich Cantonal Bank's Celyad Oncology SA American Depositary Shares position peaked at $601K in Q1 2016.
9 funds tracked by Wall St. Rank held Celyad Oncology SA American Depositary Shares as of Q4 2019.

Based on Zurich Cantonal Bank's 13F filing for Q4 2019, filed 21 Jan 2020.